Clinical Trials
4 trialsNCT03443635 2022-04-29
CHOP
Tulane University
Phase 1/2 Completed
NCT04834089 2021-04-08
SOROCOV
Butantan Institute
Phase 1/2 Unknown
NCT02000817 2019-06-24
Investigation of Otelixizumab in New-Onset, Autoimmune Type 1 Diabetes Mellitus Patients
GlaxoSmithKline
Phase 1/2 Completed
NCT00587132 2013-06-24
Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma
Mayo Clinic
Phase 1/2 Terminated